Dai Jianping 4
4 · Cellular Biomedicine Group, Inc. · Filed Apr 2, 2013
Insider Transaction Report
Form 4
Dai Jianping
Director
Transactions
- Award
Non-Qualified Stock Option
2013-03-29+5,300→ 5,300 totalExercise: $4.95Exp: 2023-03-29→ Common stock (5,300 underlying)
Footnotes (1)
- [F1]This option vests according to the following schedule: 1/36th per month following the vesting commencement date of March 29, 2013.